We investigated the relationship between serum leptin concentration, serum lipid profile and other blood biochemistry parameters in healthy post-menopausal women. Blood samples for analysis of serum leptin concentration, blood biochemistry and hormonal status, and urine samples for calcium measurement were taken from 122 women. No significant correlation was found between serum leptin concentration and serum lipid profile. The concentration of serum leptin was significantly associated with body mass index (BMI), luteinizing hormone (LH) and alanine transaminase (ALT). BMI was found to be a statistically significant independent factor for serum leptin concentration. We conclude that leptin was not associated with serum lipids and lipoproteins in post-menopausal women. Leptin was associated with BMI, ALT and LH, however, with BMI being an independent predictor of leptin concentration. There was a relationship between LH and serum leptin concentration even after menopause, and ALT correlated with serum leptin concentration through BMI.
Introduction
Leptin, a member of the helical cytokine family, is the 16 kDa product of the ob gene on human chromosome 7q31.3. 1 Leptin is thought to control the body's fat load by suppressing the secretion of neuropeptide Y (NPY), a hypothalamic peptide that stimulates eating. 2 The number of adipocytes determines the circulating leptin concentration.
High leptin concentrations have been linked to both obesity and an increased risk of high cholesterol levels and heart disease. As obesity is a determinant of serum lipids and lipoproteins in adults, 3 leptin might have a correlation with serum lipids and lipoproteins. Previous studies mostly focused on the role of leptin in cardiac pathologies rather than a direct correlation between leptin concentration and serum lipids.
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We aimed to assess if leptin concentration is associated with the serum lipid profile and/or other parameters of blood biochemistry in post-menopausal women.
Patients and methods

STUDY POPULATION
Women who had been post-menopausal for at least 12 months, and had visited the Dr Zekai Tahir Burak Women's Health Education and Research Hospital for evaluation and treatment of osteoporosis, were enrolled into this prospective study. Subjects with diabetes mellitus, known cardiovascular and metabolic bone diseases, or who were on medication such as lipid-lowering drugs, corticosteroids, thyroid hormone, hormone replacement therapy or any bone antiresorptive drugs were excluded from the study.
The ethical committee approved the study protocol. All patients were informed about the aim of the study, and gave written consent.
CLINICAL MEASUREMENTS
Height and weight were measured and body mass index (BMI) was calculated as body weight (kg) divided by height in metres squared (kg/m 2 ).
SAMPLE COLLECTION
Fasting-state venous blood samples were obtained from each patient, between 08.00 and 10.00, for follicle-stimulating hormone (FSH), luteinizing hormone (LH), oestradiol, total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), triglyceride (TG), alanine transaminase (ALT), aspartate transaminase (AST), calcium, phosphorus, creatinine, blood urea nitrogen (BUN), alkaline phosphatase (ALP), glucose and leptin determinations. Urine samples were taken from each patient to determine calcium concentrations. All samples were centrifuged within 1 h of collection and stored at -70 o C until analysed.
BIOCHEMICAL ANALYSIS
Serum leptin concentrations were measured using a commercial two-site immunoradiometric assay for human leptin (DSL-23100 ACTIVE ® Leptin Coated-Tube Immunoradiometric Assay Kit; Diagnostic System Laboratories, Inc., Webster, TX, USA). The intra-and inter-assay coefficients of variation were 3.7% and 5.2%, respectively. The sensitivity of the assay was 0.1 ng/ml. Serum concentrations of FSH (Immulite 2000 Analyzer ® , EURO/DPC Ltd, Gwynedd, UK; intra-assay variation of 4.0%, inter-assay variation of 6.7%), LH (Immulite 2000 Analyzer; intra-assay variation of 4.8%, inter-assay variation of 10.7%), and oestradiol (Immulite 2000 Analyzer; intraassay variation of 6.7%, inter-assay variation of 9.7%) were determined.
All biochemical analyses of blood and urine samples were performed with commercial kits (Modular P 800 + ISE 900, Roche Diagnostics, Mannheim, Germany). The intra-and inter-assay coefficient variations of ALP, serum calcium, serum phosphorus, urine calcium, BUN, serum creatinine, total cholesterol, triglyceride, LDL, HDL, VLDL, ALT, AST and serum glucose were all less than 3%.
STATISTICAL ANALYSIS
Data were stored and analysed using SPSS ® version 9.0 (SPSS Inc., Chicago, USA) for Windows. Measurements of variables were expressed as the mean ± SD for descriptive statistics and a P-value < 0.05 was considered statistically significant. To determine the relationship between leptin concentration and other variables, Spearman Rank Correlation Analysis was used. Variables affecting leptin concentration were analysed using bivariate and multivariate linear regression. 
Results
A total of 122 post-menopausal women were enrolled in the study. Table 1 shows their clinical characteristics and the findings of the biological and biochemical analyses.
The mean serum leptin concentration was 37.25 ± 15.12 ng/ml and leptin was found to be significantly associated with BMI, LH and ALT (P < 0.001, P = 0.045 and P = 0.01, Table 2 ). No significant correlation was found between serum leptin concentration and serum lipid profile. The serum leptin concentration was not correlated with any other parameters assessed. Table 3 shows a multiple regression model fitted to the data. Only BMI was found to be a significant independent factor associated with serum leptin concentration as demonstrated by β coefficient, partial r 2 and P-values of 2.61, 0.549 and < 0.001, respectively. It should be noted that LH was almost a significant independent predictor of serum leptin concentration (P = 0.0689). 
Discussion
The fat cell plays an important role in the energy balance axis. Abnormal fat cell metabolism leads to many deleterious consequences for body weight and insulin sensitivity. One of them is the disruption of the balance between lipolysis and lipogenesis leading to excessive free fatty acid release. As leptin is synthesized and secreted mostly by white adipose tissue as the product of the ob gene, 4 -6 an association between leptin secretion and serum lipids and lipoproteins may exist. Takahashi-Yasuno et al. 7 demonstrated that the leptin receptor Ob-R Arg223Gln polymorphism in Japanese men was associated with a significant elevation of serum TC and LDL-C concentrations. In our study, we tried to determine if there was any correlation between serum leptin concentration and the concentration of serum lipids and lipoproteins, in addition to other blood biochemistry parameters, in post-menopausal women with osteoporosis.
Leptin has been shown in vitro to increase the oxidation of fatty acids and the depletion of triglycerides in adipocytes. 8 Thus, leptin may have a negative effect on serum lipids. Leptin concentration was not found to be associated with serum lipids and lipoproteins in this study, however. The mean serum lipid and lipoprotein concentrations were within the normal limits; no individual correlation was established between serum leptin concentration and any other blood biochemistry parameters.
Valle et al., 9 in their study of a group of obese children, found in a single linear correlation analysis that leptin correlated with different metabolic syndrome variables (insulin, triglycerides, HDL-C, Apolipoprotein-AI, sex hormone binding globulin and plasminogen activator inhibitor-I). Leptin was not an independent predictive factor for any of them except insulin, however. 9 Elevated plasma leptin concentration was strongly suggested to predict first-ever acute myocardial infarction in men, 10 and recently it has been shown as an independent risk factor for coronary heart disease. 11 Ciccone et al. 12 reported that plasma leptin concentrations were independently associated with the intima-media thickness (IMT) of the common carotid artery, suggesting that the increase of adipose tissue mass (or leptin per se) may have an unfavourable influence on the development of atherosclerosis. In their study, the association between IMT and leptin was dependent and/or confounded by the relationship between IMT and obesity. 12 This would suggest that leptin seems to have effects on the cardiovascular system that are independent of any changes to serum lipids and lipoproteins.
In our study, BMI, ALT and LH were associated with serum leptin concentration. BMI, however, was the only statistically significant independent predictor of leptin concentration, but LH was almost a statistically significant predictor. It is well known that leptin concentration increases with increasing BMI, 13 -15 and various investigators have shown that serum ALT activity is independently related to BMI. 16, 17 As a result of our findings, we would suggest that the correlation between ALT and leptin is through BMI, as we found that ALT was not an independent predictor of leptin concentration.
Leptin has been shown to affect the secretion of several hormones including LH. 18 The leptin receptor is present at both hypothalamic and adenohypophyseal loci, 19 -21 and in vitro studies using explants collected from normal-fed rodents indicate that leptin can act directly at both sites to stimulate the release of gonadotrophinreleasing hormone and LH, respectively. 22, 23 Amstalden et al. 24 showed that leptin affected the secretion of LH in the mature cow, in part, by its direct action at the adenohypophysis. It is thought that leptin either regulates or contributes significantly to the regulation of LH secretion. 25 The correlation between leptin and LH has been shown in animal studies and premenopausal women. In our study, however, we have shown that LH may still have a strong correlation with serum leptin concentration after menopause.
There was no significant association found between serum leptin concentration and oestradiol in our study. A study by Shimizu et al. 26 suggested that oestradiol raises leptin concentration in humans and they found that serum leptin concentration was about 33% higher during the luteal phase of the menstrual cycle, while oestradiol concentrations were two-fold higher compared with the follicular phase. This would suggest that serum leptin concentration would be lower in the post-menopausal period. This was reported by Rosenbaum et al., 27 who demonstrated that pre-menopausal women have higher serum leptin concentrations than their post-menopausal counterparts, and by Shimizu et al., 28 who reported that pre-menopausal women demonstrated higher leptin production than postmenopausal women. There are reports, however, indicating that oestrogen has no S Oguz, H Aytan, OL Tapisiz et al. Leptin and serum lipid profile in post-menopausal women direct effect on adipose tissue leptin production. 29, 30 Douchi et al. 31 reported that post-menopausal status, at least clinically, does not have a significant impact on circulating leptin concentration. Hadji et al. 32 also showed that serum leptin concentrations were not influenced by hormone replacement therapy use or oestradiol concentrations. The effect that oestrogen has on leptin production remains controversial, therefore.
We found that leptin concentration was not associated with serum lipids and lipoproteins in post-menopausal women. Leptin concentration was associated with BMI, ALT and LH, BMI being an independent predictor of leptin concentration. Our results suggest that LH has a relationship with serum leptin concentration even after menopause, and ALT was correlated with serum leptin through BMI.
